Pradip Kumar Ganguly

Comparison of Toxicity Associated With Early Morning Versus Late Afternoon Radiotherapy in Patients With Head-and-Neck Cancer: A Prospective Randomized Trial of the National Cancer Institute of Canada Clinical Trials Group (HN3)

Georg A. Bjarnason, Robert G. MacKenzie, Abdenour Nabid et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 106 citations

National Cancer Institute, Radiation Therapy, Medicine +7

Dexamethasone for the Prophylaxis of Radiation-Induced Emesis: A National Cancer Institute of Canada Clinical Trials Group Phase III Study

Andrea Bezjak, Joseph L. Pater, Benny Zee et al. · Journal of Clinical Oncology · 2000 · 81 citations

Prophylaxis of Radiation-Associated Mucositis in Conventionally Treated Patients With Head and Neck Cancer: A Double-Blind, Phase III, Randomized, Controlled Trial Evaluating the Clinical Efficacy of an Antimicrobial Lozenge Using a Validated Mucositis Scoring System

S. El-Sayed, Abdenour Nabid, Wendy Shelley et al. · Journal of Clinical Oncology · 2002 · 75 citations

Prevention of Postlaryngectomy Pharyngocutaneous Fistula: The Memorial University Experience

Thomas J. Smith, Kenneth J. Burrage, Pradip Kumar Ganguly et al. · The Journal of Otolaryngology · 2003 · 59 citations

A phase I dose escalation study of a humanized monoclonal antibody to EGFR (hR3) in patients with locally advanced squamous cell cancer of the head and neck (SCCHN) treated with radiotherapy

Abdenour Nabid, Pradip Kumar Ganguly, V.M. Venkatesan et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 32 citations · Full text

Squamous Cell Cancer, Radiation Therapy, Medicine +9